McCreary Josh A 4
4 · NATIONAL HEALTHCARE CORP · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
NHC General Counsel Josh McCreary Receives Restricted Share Award
What Happened
- Josh A. McCreary, Senior Vice President & General Counsel of National Healthcare Corp. (NHC), was granted 1,458 restricted shares on February 27, 2026. The shares were awarded at a recorded price of $0 (an equity award/grant), so no cash was paid by the insider at grant.
Key Details
- Transaction date: 2026-02-27 (reported on Form 4 filed 2026-03-03).
- Transaction type/code: Award/Grant (A).
- Shares granted: 1,458; grant price shown as $0 (no cash purchase).
- Shares owned after transaction: not specified in the filing.
- Footnote: The restricted shares vest 33 1/3% on 1/1/2027, 33 1/3% on 1/1/2028, and 33 1/3% on 1/1/2029.
- No 10b5-1 plan, tax-withholding, or sale disposition noted in this filing.
Context
- This is a compensation-related equity award (restricted stock) subject to multi-year vesting; such grants are common for executive retention and alignment with shareholders. Until vested, the shares typically cannot be sold or freely transferred. Awards recorded at $0 reflect an award rather than an open-market purchase and do not by themselves indicate the insider is buying or selling stock.
Insider Transaction Report
Form 4
McCreary Josh A
Senior VP & General Counsel
Transactions
- Award
Common Stock
[F1]2026-02-27+1,458→ 11,400 total
Holdings
- 4,000
Option to Purchase Common Stock
Exercise: $53.94From: 2024-03-08Exp: 2028-03-08→ Common Stock (4,000 underlying) - 8,000
Option to Purchase Common Stock
Exercise: $94.10From: 2025-03-05Exp: 2029-03-05→ Common Stock (8,000 underlying) - 13,500
Option to Purchase Common Stock
Exercise: $90.62From: 2026-02-24Exp: 2030-02-24→ Common Stock (13,500 underlying) - 14,000
Option to Purchase Common Stock
Exercise: $157.13From: 2027-02-23Exp: 2031-02-23→ Common Stock (14,000 underlying)
Footnotes (1)
- [F1]Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029.
Signature
/s/ Josh McCreary|2026-03-03